Immunology pp 289-301 | Cite as

Role of Prostaglandins in Macrophage Cell Function

  • Steven L. Kunkel
  • Stephen W. Chensue
  • Joseph C. Fantone
  • Peter A. Ward


Since their discovery in the 1930s as potent autacoids, and their subsequent isolation and characterization in the 1960s as derivatives of arachidonic acid, prostaglandins have been the topic of many symposia and the basis for exhaustive research. These ubiquitous fatty acid derivatives have proven to be extremely powerful chemicals synthesized by nearly every cell in the human body, except the erythrocyte. Their synthesis and release have shown to be dependent upon a wide variety of cell membrane perturbations ranging from slight mechanical or chemical disturbances to the binding of compounds to specific receptors. Increasing evidence supports the theory that prostaglandins of all types are “made on demand” and not stored, since the amount of prostaglandins released from specific cells, in response to an appropriate stimulus, is greater than the total prostaglandin content of the cells prior to stimulation (Horton, 1979).


Phorbol Myristate Acetate Mononuclear Phagocyte Phorbol Myristate Acetate Mouse Peritoneal Macrophage Granulomatous Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Babior, B. M., 1978, Oxygen-dependent microbial killing by phagocytes, N. Engl. J. Med. 298:659.PubMedCrossRefGoogle Scholar
  2. Bockman, R. S., 1981, Prostaglandin production by human blood monocytes and mouse peritoneal macrophages: Synthesis dependent on in vitro culture conditions, Prostaglandins 21:9.PubMedGoogle Scholar
  3. Bonney, R. J., Wightman, P. D., Davies, P., Kuehl, F. A., and Humes, J. L., 1978, Regulation of prostaglandin synthesis and of selective release of lysosomal hydrolases by mouse peritoneal macrophage, Biochem. J. 176:433.PubMedGoogle Scholar
  4. Bonney, R. J., Naruns, P., Davies, P., and Humes, J. L., 1979, Antigen—antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages, Prostaglandins 18:605.PubMedGoogle Scholar
  5. Bonta, I. L., and Parnham, M. J., 1978a, Prostaglandins and chronic inflammation, Biochem. Pharmacol. 27:1611.PubMedCrossRefGoogle Scholar
  6. Bonta, I. L., and Parnham, M. J., 1978b, Time-dependent pro and anti-inflammatory effects of prostaglandin (PG) E1 on experimental granulomata in rats, Br. J. Pharmacol. 62: 417.Google Scholar
  7. Bonta, I. L., and Parnham, M. J., 1979, Cannulated sponge implants in rats for the study of timedependent pharmacological influences on inflammatory granulomatous. J. Pharmacol. Methods 2:1.CrossRefGoogle Scholar
  8. Bonta, I. L., Parnham, M. J., and Adolfs, M. J. P., 1977, Reduced exudation and increased tissue proliferation during chronic inflammation in rats deprived of endogenous prostaglandin precursors, Prostaglandins 14:295.PubMedGoogle Scholar
  9. Boros, D. L., 1978, Granulomatous inflammations, Prog. Allergy 24:183.PubMedGoogle Scholar
  10. Brogt, P. C., and Bonta, I. L., 1979, In vivo metabolism of [1-14C]arachidonic acid during different phases of granuloma development in the rat, Biochem. Pharmacol. 28:1581.CrossRefGoogle Scholar
  11. Davies, P., and Allison, A. C., 1976, The macrophage as a secretory cell in chronic inflammation, Agents Actions 6:60.PubMedCrossRefGoogle Scholar
  12. Davies, P., Bonney, R. J., Humes, J. L., and Kuehl, F. A. 1980, The synthesis of arachidonic acid oxygenation products by various mononuclear phagocyte populations, in: Mononuclear Phagocytes (R. van Furth, ed.), pp. 1317–1350, Nijhoff, The Hague.CrossRefGoogle Scholar
  13. Farzod, A., Penneys, N. S., Ghaffar, A., Zibah, V. A., and Schlassberg, J., 1977, PGE2 and PGF biosynthesis in stimulated and nonstimulated peritoneal preparations containing macrophages, Prostaglandins 14:829.Google Scholar
  14. Goldyne, M. E., 1977, Prostaglandins and the modulation of immunological responses, Int. J. Dermatol. 16:701.PubMedCrossRefGoogle Scholar
  15. Goodwin, J. S., and Webb, D. R., 1980, Regulation of the immune response by prostaglandins, Clin. Immunol. Immunopathol. 15:106.PubMedCrossRefGoogle Scholar
  16. Goodwin, J. S., Bankhurst, A. D., and Messner, R. P., 1977, Suppression of human T-cell mitogenesis by prostaglandin: Existence of a prostaglandin-producing suppressor cell, J. Exp. Med. 146:1719.PubMedCrossRefGoogle Scholar
  17. Hansen, H. S., 1976, 15-Hydroxyprostaglandin dehydrogenase: A review, Prostaglandins 12:647.PubMedGoogle Scholar
  18. Henney, C. S., Bourne, H. R., and Lichtenstein, L. M., 1971, The role of cyclic AMP in the specific cytolytic activity of lymphocytes, J. Immunol. 108:1526.Google Scholar
  19. Higgs, G. A., Higgs, E. A., and Solman, J. A., 1979, Prostacyclin and inflammation, in: Prostacyclin (J. R. Vane and S. Bergstrom, eds.), pp. 187–193, Raven Press, New York.Google Scholar
  20. Horton, E. W., 1979, Prostanoids in health and disease, in: Chemistry, Biochemistry, and Pharmacological Activity of Prostanoids (S. M. Roberts and F. Scheinmann, eds.), pp. 1–16, Pergamon Press, Elmsford, N.Y.Google Scholar
  21. Humes, J. L., Bonney, R. J., Pelus, L., Dahlgron, M. E., Kuehl, F. A., and Davies, P., 1977, Macrophages synthesize and release prostaglandins in response to inflammatory stimuli, Nature (London) 269:149.CrossRefGoogle Scholar
  22. Humes, J. L., Davies, P., Bonney, R. J., and Kuehl, F. A., 1978, Phorbol myristate acetate (PMA) stimulates the release of arachidonic acid and its cyclooxygenation products by macrophages, Fed. Proc. 37:1318.Google Scholar
  23. Johnson, K. J., Fantone, J. C., Kaplan, J., and Ward, P. A., 1981, In vivo damage of rat lungs by oxygen metabolites, J. Clin. Invest. 67:983.PubMedCrossRefGoogle Scholar
  24. Klebanoff, S. J., and Hansen, C. B., 1975, Antimicrobial systems of mononuclear phagocytes, in: Mononuclear Phagocytes in Immunity, Infection and Pathology (R. van Furth, ed.), pp. 507–517, Blackwell, Oxford.Google Scholar
  25. Kunkel, S. L., Thrall, R. S., Kunkel, R. G., Ward, P. A., and Zurier, R. B., 1979, Suppression of immune complex vasculitis in rats by prostaglandins, J. Clin. Invest. 64:1525.PubMedCrossRefGoogle Scholar
  26. Kunkel, S. L., Fantone, J. C., Ward, P. A., and Zurier, R. B., 1981a, Modulation of inflammatory reactions by prostaglandins, Prog. Lipid Res. 20:249.Google Scholar
  27. Kunkel, S. L., Ogawa, H., Conran, P., Ward, P. W., and Zurier, R. B., 1981b, Suppression of acute and chronic inflammation by orally administered prostaglandins, Arthritis Rheum. 24:1151.PubMedCrossRefGoogle Scholar
  28. Kurtland, J. I., Broxmeyer, H. E., Pelus, L. M., Bickman, R. S., Moore, M. A. S., 1978, Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation, Blood 52:388.Google Scholar
  29. Lehmeyer, J. E., and Johnson, R. B., 1978, Effects of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgG, Clin. Immunol. Immunopathol. 9:482.PubMedCrossRefGoogle Scholar
  30. Lichtenstein, L. M., and DiBernardo, R., 1971, The immediate allergic response: In vitro action of cyclic AMP and other drugs on the two stages of histamine release, J. Immunol. 107:1131.PubMedGoogle Scholar
  31. Oort, J., and Scheper, R. J., 1977, Histopathology of acute and chronic inflammation, Agents Actions Suppl. 3:25.PubMedGoogle Scholar
  32. Oropeza-Rendon, R. L., Speth, V., Hiller, G., Weber, K., and Fischer, H., 1979, Prostaglandin E1 reversibly induces morphological changes in macrophages and inhibits phagocytosis, Exp. Cell Res. 119:365.PubMedCrossRefGoogle Scholar
  33. Parker, C. W., 1972, The role of prostaglandins in the immune response, in: Prostaglandins in Cellular Biology (P. W. Ramwell and B. B. Pharriss, eds.), pp. 173–190, Academic Press, New York.CrossRefGoogle Scholar
  34. Pelus, L. M., and Strausser, H. R., 1977, Prostaglandins and the immune response, Life Sci. 20:903.PubMedCrossRefGoogle Scholar
  35. Ramwell, P., 1980, General introduction to clinical implications of prostaglandin synthetase inhibition, in: Prostaglandin Synthetase Inhibitors: New Clinical Applications (P. Ramwell, ed.), p. 5, Liss, New York.Google Scholar
  36. Rivikin, I., Rosenblatt, J., and Becker, E. L., 1975, The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils, J. Immunol. 115:1126.Google Scholar
  37. Smith, R. L., and Weidemann, M. J., 1980, Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages, Biochem. Biophys. Res. Commun. 97:973.PubMedCrossRefGoogle Scholar
  38. Trang, L. E., 1977, Levels of prostaglandin F2 alpha and E1 and thromboxane B1 in joint fluid in rheumatoid arthritis, Scand. J. Rheum. 6:151.PubMedCrossRefGoogle Scholar
  39. Tsurufuji, S., Sato, H., Min, K. R., and Ohuchi, K., 1978, Difference in the anti-inflammatory effects of indomethacin between acute and chronic stages of carrageenin-induced inflammation, J. Pharm. Dyn. 1:8.CrossRefGoogle Scholar
  40. Vane, J. R., 1976, Prostaglandin as mediators of inflammation in: Advances in Prostaglandin and thromboxane Research (B. Samuelson and R. Paoletti, ed.), Raven Press, New York, pp. 791–798.Google Scholar
  41. Warren, K. S., Mahmoud, A. A. F., Boros, D. L., Rall, T. W., and Carpenter, C. C. J., 1974, In vivo suppression by cholera toxin of cell-mediated and foreign body inflammatory response. J. Immunol. 112:996.PubMedGoogle Scholar
  42. Weidemann, M. J., Peskar, B. A., Wrongemann, K., Reitschel, E. T., and Fischer, H., 1978, Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence, FEBS Lett. 89:136.PubMedCrossRefGoogle Scholar
  43. Zurier, R. B., Weissman, G., Hoffstein, S., Kammermann, S., and Tiu, M. H., 1974, Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists and agents which affect microtubule function, J. Clin. Invest. 53:297.PubMedCrossRefGoogle Scholar
  44. Zurier, R. B., Damjarrow, I., Miller, P. L., and Biewer, B. F., 1978, Prostaglandin E treatment prevents progression of nephritis in murine lupus erythematosus, J. Clin. Lab. Immunol. 1:95.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Steven L. Kunkel
    • 1
  • Stephen W. Chensue
    • 1
  • Joseph C. Fantone
    • 1
  • Peter A. Ward
    • 1
  1. 1.Department of PathologyUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations